doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 130
2023
-
Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma
Journal of cancer research and clinical oncology, year: 2023, DOI
-
Next generation proteomics identifies a potential protein marker of poor response to tyrosine kinase inhibitors in metastatic renal cell carcinoma
Year: 2023, type: Conference abstract
2022
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Proteomics, year: 2022, volume: 22, edition: 7, DOI
-
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
Diagnostics, year: 2022, volume: 12, edition: 7, DOI
-
DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
Year: 2022, type: Conference abstract
-
LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro
JOURNAL OF CLINICAL LABORATORY ANALYSIS, year: 2022, volume: 36, edition: 6, DOI
-
Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2022, volume: 40, edition: 3, DOI
-
Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers
Biomedical Papers, Olomouc: Palacky University, year: 2022, volume: 166, edition: 1, DOI
-
Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
Year: 2022, type: Conference abstract
-
Proteotype classification of renal cell carcinoma for prognosis and therapy response
Year: 2022, type: Conference abstract